<DOC>
	<DOCNO>NCT02322047</DOCNO>
	<brief_summary>The purpose study see whether drug prazosin naltrexone decrease alcohol craving drink individual problem alcohol use alcohol risky level past 90 day . Prazosin medication FDA approve treat people high blood pressure . Some study show prazosin may also decrease nightmare improve sleep Veterans suffer Posttraumatic Stress Disorder ( PTSD ) . The use prazosin PTSD nightmares off-label use . That mean FDA approve prazosin PTSD nightmare . The current study evaluate `` off-label '' use prazosin determine whether helpful decrease alcohol craving consumption among people alcohol problem . Naltrexone medication FDA approve treat alcohol problem . This study sponsor Department Defense Congressionally Directed Medical Research Program ( DoD/CDMRP ) . We expect approximately 240 participant study , run approximately 4 year . Study participant involve study 7 week , complete Final Assessment .</brief_summary>
	<brief_title>Prazosin Naltrexone ( PaN ) Study Veterans With Alcohol Use Disorders</brief_title>
	<detailed_description>In context propose double-blind , double-dummy , placebo control study prazosin naltrexone participant undergo two crave induction , one orient towards relief crave towards reward crave . Daily IVR ( Interactive Voice Recording System ) data crave consumption PTSD symptomatology collect 7 day immediately follow initial assessment visit establish pre-medication baseline . One hundred twenty individual adequate IVR compliance whose screen lab test indicate safe take study medication enter medication phase study within 14 day initial assessment initiating prazosin/placebo well 50mg naltrexone/placebo treatment . Randomization block gender , PTSD status , desire abstain vs. desire cut . Prazosin titrate three time daily dosing ( 9 : 4mg ; 3pm : 4 mg ; 9pm : 8mg ) end two week . Naltrexone take daily 50 mg/day titration schedule . The stable dose medication continue four week medication compliance evaluate pill count , IVR daily monitoring , riboflavin trace urine analysis . On approximately day 49 participant come lab craving induction ( two week window day 49 participant may still see schedule issue arise ) . The order crave induction counterbalance , administration separate time 30 minute minimize carry . Subjective response crave induction obtain via relief orient crave item reward orient crave item Desire Alcohol Questionnaire . Participants assist return craving level baseline prior debrief . They offer VA community referral treatment . Both prazosin naltrexone safely discontinue without taper .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Current primary DSMV diagnosis alcohol use disorder Heavy drinking last 30 day At least 18 year age Good general medical health ( see Exclusion Criteria ) Capacity provide inform consent English fluency literacy Veteran US military Psychiatric/behavioral : psychiatric disorder require medication antidepressant ; currently take disulfiram , acamprosate , naltrexone plan take medication 8week medication phase study ; current dependence psychoactive substance nicotine cannabis ; current diagnosis opioid abuse , use opioid containing medication benzodiazepine previous month , UDA positive opioids , benzodiazepine , sedative hypnotic . Medical : significant acute chronic medical illness ; woman pregnant , nurse infant ( ) , childbearing potential use contraceptive method judge study physician PA effective ; sign symptom alcohol withdrawal time initial consent ; men use trazodone , vardenafil , tadalafil sildenafil . Legal involvement could interfere study treatment . Individuals court order treatment eligible participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>